Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Clinical trial NCT07364747 · RECRUITING

Trial details

NCT number: NCT07364747
Sponsor: Siriraj Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cisplatin-induced Ototoxicity Sensorineural Hearing Loss Ototoxicity Ototoxicity, Drug-Induced

Start date: 2024-12-23
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.